CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.CELZEarnings & Financial Report
The Institute for Creative Technologies (ICT) is a University Affiliated Research Center at the University of Southern California located in Playa Vista, California. ICT was established in 1999 with funding from the US Army.
Revenue
$0
Gross Profit
$0
Operating Profit
$-1.1M
Net Profit
$-1.0M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.75
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Q3 FY2024 Financial Summary
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported revenue of $0 for Q3 FY2024, with a net profit of $-1.0M (up 28.5% YoY) (N/A margin). Cost of goods sold was $0, operating expenses totaled $1.1M.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-1.0M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 FY2024 |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Annual Revenue by Year
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. annual revenue history includes year-by-year totals (for example, 2023 revenue was $9.0K).
| Year | Annual Revenue |
|---|---|
| 2023 | $9.0K |
| 2022 | $88.6K |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Quarterly Revenue & Net Profit History
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $0 | — | $-1.2M | N/A |
| Q2 FY2025 | $0 | — | $-1.2M | N/A |
| Q3 FY2024 | $0 | — | $-1.0M | N/A |
| Q2 FY2024 | $8.0K | — | $-1.6M | -19471.6% |
| Q1 FY2024 | $0 | — | $-1.0M | N/A |
| Q4 FY2023 | $3.0K | -83.9% | N/A | N/A |
| Q3 FY2023 | $6.0K | -89.1% | $-1.5M | -24232.5% |
| Q2 FY2023 | $0 | — | $-1.1M | N/A |
Income Statement
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $6000 | $3000 | $0 | $8000 | $0 | $0 | $0 |
| YoY Growth | N/A | -89.1% | -83.9% | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.1M | $12.5M | $10.7M | $9.6M | $8.0M | $6.9M | $7.1M | $5.9M |
| Liabilities | $398527 | $421159 | $371394 | $390959 | $376272 | $330908 | $277644 | $261353 |
| Equity | $13.7M | $12.1M | $10.3M | $9.2M | $7.6M | $6.6M | $6.8M | $5.6M |
Cash Flow
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-986737 | $-1.3M | $-8.0M | $-896864 | $-1.5M | $-985588 | $-1.2M | $-1.2M |